COPD Outcomes Improved Significantly When Patients and Doctors Used a Digital Health Tool, Propeller Health Study Finds
November 25 2019 - 6:00AM
Business Wire
Patients at Louisville’s JenCare Senior Medical
Center saw decreases in rescue medication use and increases in days
without rescue use over a 12-month period
Patients with chronic obstructive pulmonary disease (COPD) at
Louisville’s JenCare Senior Medical Center, a ChenMed company, saw
their health outcomes improve significantly when their primary care
physicians (PCPs) encouraged using Propeller’s digital health tool
to manage their COPD, reports new research by Propeller Health,
JenCare, ChenMed, and the Center for Healthy Air, Water and Soil
investigators published in JMIR Formative Research.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20191125005268/en/
For this study, 190 patients with COPD were given access to
Propeller’s digital health tool, which works by attaching a small
sensor to a patient’s existing inhaler. Propeller collects data on
medication use and sends medication reminders, progress reports and
disease insights to the patient’s smartphone or hub, as well as
reports to their doctor. The JenCare patients participated as part
of the larger AIR Louisville program, which was a collaborative
effort to address respiratory disease in Jefferson County, built on
partnerships with Mayor Greg Fischer, multiple city agencies, an
environmental institute, and local health systems, payers,
employers and community groups.
JenCare study participants worked closely with their clinicians
to enroll in the program. Clinicians then leveraged real-time data
points from Propeller to recommend adjustments to their patients’
personalized care plans.
Patients were monitored over the course of 12 months. At three,
six and 12 months, patients demonstrated significant reductions in
daily rescue medication use and nighttime rescue medication use, as
well as an increase in days without symptoms necessitating rescue
use. Over the course of 12 months, daily use of rescue medication
decreased by 59% and days without symptoms necessitating rescue use
increased by 36%.
COPD is the fourth leading cause of death in the United States
and is predicted to become the number three cause of death globally
by 2030. The disease is associated with progressive loss of lung
function and has significant impacts on patients’ physical and
mental well-being.
“COPD can have a devastating impact on the people it affects,”
said Meredith Barrett, PhD, vice president of research at Propeller
Health. “The use of a digital health tool to manage COPD can lift
some of the burden of the disease and go a long way in improving
day-to-day quality of life, particularly when clinicians and
patients engage together with the data.”
Compared to previous studies, which have shown that digital
health engagement may fall off after three months, this study
showed 81% retention and 90% engagement in patients at the
six-month mark, suggesting that digital health tools are
particularly effective at keeping patients engaged long-term when a
clinical care team is involved.
JenCare patients average 208 minutes yearly of face-to-face time
with their primary care doctor, more than 10 times the national
average, a level of interaction that may have enhanced patient
compliance and study outcomes in this study.
“This program was able to minimize the burden on providers while
maximizing patient engagement in their own care, leading to
significantly better outcomes and a stronger alliance between
patient and provider,” said Jessica Chen, MD, Chief Quality Officer
at ChenMed. “Propeller helped COPD patients partner with their
providers to better understand and manage their condition.”
About Propeller Health
Propeller Health is a leading digital health company dedicated
to making life better for every person with chronic respiratory
disease. Propeller creates products to more effectively treat
chronic respiratory disease and improve clinical outcomes for
patients through connectivity, analytics, and companion digital
experiences. The Propeller platform is used by patients, physicians
and healthcare organizations in the United States, Europe and Asia.
Propeller Health is a wholly owned subsidiary of ResMed (NYSE: RMD,
ASX: RMD). For more information, visit www.propellerhealth.com.
About ChenMed
For seniors most in need of care, high-quality health care often
is beyond reach. ChenMed brings concierge-style medicine — and
better health outcomes — to the neediest populations. ChenMed is a
privately owned medical, management and technology company that
this summer will be operating more than 60 primary care medical
practices for seniors in Florida, Georgia, Illinois, Kentucky,
Louisiana, Ohio, Pennsylvania, and Virginia. Its brands include
Chen Senior Medical Center, Dedicated Senior Medical Center, and
JenCare Senior Medical Center.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191125005268/en/
For media (Propeller) Rachel Fields +1 630.901.8265
rachel.fields@propellerhealth.com
For media (ChenMed) James Brown +1 305.310.7214
james.brown@chenmed.com
For investors (Propeller) Amy Wakeham +1 858.836.5000
investorrelations@resmed.com
Resmed (ASX:RMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Resmed (ASX:RMD)
Historical Stock Chart
From Apr 2023 to Apr 2024